Trial Profile
Evaluation of Efficacy and Toxicity of Intensified Consolidation Therapy in AML Patients greater than or equal to 60 Years.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2012
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 27 Jul 2011 New trial record